BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva

Haitao Wang, Saman Toutounchi, Robert J Pignolo, Xiaogang Cheng, Cynthia Davis Parker, Qingde Liu, Saritha Muppa, Debra Kellogg-Yelder, Kevin J Polach, Pravin L Kotian, Yarlagadda S Babu, Xilin Chen

Open source

DOI: 10.1093/jbmrpl/ziag145
Published: 2026-08-28
Container: JBMR Plus
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jbmrpl/ziag145,
  title = {BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva},
  author = {Haitao Wang and Saman Toutounchi and Robert J Pignolo and Xiaogang Cheng and Cynthia Davis Parker and Qingde Liu and Saritha Muppa and Debra Kellogg-Yelder and Kevin J Polach and Pravin L Kotian and Yarlagadda S Babu and Xilin Chen},
  year = {2026},
  journal = {JBMR Plus},
  doi = {10.1093/jbmrpl/ziag145},
  url = {https://doi.org/10.1093/jbmrpl/ziag145}
}

RIS

TY  - JOUR
TI  - BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva
AU  - Haitao Wang
AU  - Saman Toutounchi
AU  - Robert J Pignolo
AU  - Xiaogang Cheng
AU  - Cynthia Davis Parker
AU  - Qingde Liu
AU  - Saritha Muppa
AU  - Debra Kellogg-Yelder
AU  - Kevin J Polach
AU  - Pravin L Kotian
AU  - Yarlagadda S Babu
AU  - Xilin Chen
PY  - 2026
JO  - JBMR Plus
DO  - 10.1093/jbmrpl/ziag145
UR  - https://doi.org/10.1093/jbmrpl/ziag145
ER  -

APA

Wang, H., Toutounchi, S., Pignolo, R. J., Cheng, X., Parker, C. D., Liu, Q., Muppa, S., Kellogg-Yelder, D., Polach, K. J., Kotian, P. L., Babu, Y. S., & Chen, X. (2026). BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva. JBMR Plus. https://doi.org/10.1093/jbmrpl/ziag145

Source records

crossref · retrieved 2026-09-25T23:59:00.414Z